Tavapadon – does it work well? When do you think it will be launched in Sweden? At what stages of Parkinson’s disease do you think it will be prescribed?

It is a dopamine agonist that binds to various dopamine receptors in a slightly different way than previous ones. It is difficult to say when it will be approved. The other dopamine agonists are available for all stages of Parkinson’s; we will have to see how things turn out with this one. /Dag Nyholm